McKesson Tribal PPV
Past Recompete Updated
- Agency
-
Indian Health Service
Department of Health and Human Services
- Solicitation expected
- By GovTribe estimate
- Estimated value
- $100,000,000 or more
- Set-aside
- No set-aside
Forecast facts
- Incumbent contract
-
- 36W79720D0001 Federal IDV award held by Mckesson Corporation Ordering ends Aug 9, 2028 · Ceiling $61,806,317,159
- Previous solicitation
- Pharmaceutical Prime Vendor 2020 36W79719R0001 · Posted Aug 28, 2019
- Anticipated award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Points of contact
-
- Weston Thompson weston.thompson@ihs.gov (405) 951-3996
- Sean Long sean.long@ihs.gov (918) 342-6509
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Department of Health and Human Services Indian Health Service (IHS) is forecasting a recompete contract for Pharmaceutical Supplies Tribal PPV, with an estimated award date of August 1, 2026. The opportunity, categorized under Pharmaceutical Preparation Manufacturing (NAICS 325412), will involve pharmaceutical supplies for tribal populations, with the incumbent contractor being McKesson. The contract was posted on December 10, 2025, indicating potential solicitation preparation in the near term.
While specific award values are not detailed, the contract involves pharmaceutical supplies for tribal health services, suggesting a critical healthcare procurement. The point of contact for this opportunity is Weston Thompson, NSSC Pharmacy Support Branch Supervisor, who can be reached at weston.thompson@ihs.gov or +1 (405) 951-3996, with Sean Long serving as the Contracting Officer at sean.long@ihs.gov or +1 (405) 951-3932. No specific set-aside categories are indicated, suggesting the procurement will be open to a broad range of qualified pharmaceutical suppliers.
Forecast text
Pharmaceutical Supplies Tribal PPV
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast